| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Centre de Recherche, Centre Hospitalier de l’Université de Montréal–Hôpital Saint-Luc and Department of Medicine (P.D., A.R., J.-H.B., L.R., C.A.), Université de Montréal, Montréal, Québec, Canada H2X 1P1; and Scantibodies Laboratory, Inc. (T.C.), Santee, California 92071
Address all correspondence and requests for reprints to: Pierre D’Amour, M.D., Centre de Recherche, Centre Hospitalier de l’Université de Montréal–Hôpital Saint-Luc, 264, Boulevard René-Lévesque est, Montréal (Québec), Canada H2X 1P1. E-mail: rechcalcium.chum{at}ssss.gouv.qc.ca.
Context: The quantitative evaluation of circulating PTH peaks revealed by PTH assays after HPLC separation constitutes the best way to study the behavior of PTH molecular forms, but it is also impractical.
Objective: The objective of the study was to investigate the regulation of circulating PTH molecular forms by calcium through the use of PTH fragments/PTH (1–84) ratios derived from PTH assays with different specificities before and after HPLC separation of circulating PTH.
Design: CaCl2 and Na citrate were infused in eight volunteers. PTH was measured in serum and HPLC fractions at different calcium concentrations in PTH assays reacting with regions 1–2 (CA), 12–18 (T), and 65–69 (C) of the PTH structure.
Results: From hypo- to hypercalcemia, the C/CA ratio had the highest range (1.92 to 9.75; P < 0.001), and the C/T ratio had a higher range (1.69 to 6.11; P < 0.01) than the T/CA ratio (1.15 to 1.86). Human (h) PTH (1–84) represented 32.7 and 4.3% of circulating PTH in hypo- and hypercalcemic HPLC profiles, respectively. These numbers were 5 and 0.9% for amino-terminal (N)-PTH, an amino-terminal form of PTH distinct from hPTH (1–84), 7.3 and 6.8% for non-(1–84) PTH or large C-PTH fragments with a partially preserved N structure, and 54.9 and 88.1% for C-PTH fragments missing a N structure. The HPLC C-PTH fragments to hPTH (1–84) ratio had the most extensive range (1.67 to 20.58). Despite their quantitative differences, all ratios identified identical behavior of PTH fragments relative to PTH (1–84).
Conclusions: PTH assay ratios are an adequate tool to investigate the modulation of PTH molecular forms, even if all PTH assays show some undesirable cross-reactivity with certain circulating forms of PTH.
This article has been cited by other articles:
 |
|
 |
|
  C. Valle, M. Rodriguez, R. Santamaria, Y. Almaden, M. E. Rodriguez, S. Canadillas, A. Martin-Malo, and P. Aljama Cinacalcet Reduces the Set Point of the PTH-Calcium Curve J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2430 - 2436. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Zanglis, D. Andreopoulos, and N. Baziotis Influence of L-Thyroxine Therapy on Parathyroid Hormone Concentrations Clin. Chem., June 1, 2008; 54(6): 1092 - 1093. [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Felsenfeld, M. Rodriguez, and E. Aguilera-Tejero Dynamics of Parathyroid Hormone Secretion in Health and Secondary Hyperparathyroidism Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1283 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Henrich, A. D. Rogol, P. D'Amour, M. A. Levine, J. B. Hanks, and D. E. Bruns Persistent Hypercalcemia After Parathyroidectomy in an Adolescent and Effect of Treatment With Cinacalcet HCl Clin. Chem., December 1, 2006; 52(12): 2286 - 2293. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
